Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More
Drugs Health Medical Pharma

Cipla, Novartis team up to make, market anti-diabetic drug

HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.

Read More